12,980
Views
78
CrossRef citations to date
0
Altmetric
Review Article

Recent advances in herbal medicine for treatment of liver diseases

, , &
Pages 970-988 | Received 03 Oct 2010, Accepted 21 Jan 2011, Published online: 19 May 2011

References

  • Abe Y, Ueda T, Kato T, Kohli Y. (1994). [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C]. Nippon Rinsho, 52, 1817–1822.
  • Ahmed B, Khan S, Masood MH, Siddique AH. (2008). Anti-hepatotoxic activity of cichotyboside, a sesquiterpene glycoside from the seeds of Cichorium intybus. J Asian Nat Prod Res, 10, 223–231.
  • Ajith TA, Janardhanan KK. (2002). Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat. J Ethnopharmacol, 81, 387–391.
  • Akindele AJ, Ezenwanebe KO, Anunobi CC, Adeyemi OO. (2010). Hepatoprotective and in vivo antioxidant effects of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae). J Ethnopharmacol, 129, 46–52.
  • Alqasoumi S. (2010). Carbon tetrachloride-induced hepatotoxicity: Protective effect of ‘Rocket’ Eruca sativa L. in rats. Am J Chin Med, 38, 75–88.
  • Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H. (1997). The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer, 79, 1494–1500.
  • Bao W, Li K, Rong S, Yao P, Hao L, Ying C, Zhang X, Nussler A, Liu L. (2010). Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. J Ethnopharmacol, 128, 549–553.
  • Batkhuu J, Hattori K, Takano F, Fushiya S, Oshiman K, Fujimiya Y. (2002). Suppression of NO production in activated macrophages in vitro and ex vivo by neoandrographolide isolated from Andrographis paniculata. Biol Pharm Bull, 25, 1169–1174.
  • Bhakta T, Banerjee S, Mandal SC, Maity TK, Saha BP, Pal M. (2001). Hepatoprotective activity of Cassia fistula leaf extract. Phytomedicine, 8, 220–224.
  • Bhandarkar MR, Khan A. (2004). Antihepatotoxic effect of Nymphaea stellata Willd., against carbon tetrachloride-induced hepatic damage in albino rats. J Ethnopharmacol, 91, 61–64.
  • Bhattacharjee R, Sil PC. (2007). Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties. Food Chem Toxicol, 45, 817–826.
  • Bhattacharyya D, Pandit S, Jana U, Sen S, Sur TK. (2005). Hepatoprotective activity of Adhatoda vasica aqueous leaf extract on d-galactosamine-induced liver damage in rats. Fitoterapia, 76, 223–225.
  • Bhattacharyya D, Pandit S, Mukherjee R, Das N, Sur TK. (2003). Hepatoprotective effect of Himoliv, a polyherbal formulation in rats. Indian J Physiol Pharmacol, 47, 435–440.
  • Bishayi B, Roychowdhury S, Ghosh S, Sengupta M. (2002). Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats. J Toxicol Sci, 27, 139–146.
  • Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M. (2007). Prevention of liver cirrhosis in rats by curcumin. Liver Int, 27, 373–383.
  • Chatterjee M, Sil PC. (2006). Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo. Indian J Biochem Biophys, 43, 299–305.
  • Chattopadhyay RR, Sarkar SK, Ganguly S, Banerjee RN, Basu TK, Mukherjee A. (1992). Hepatoprotective activity of Azadirachta indica leaves on paracetamol induced hepatic damage in rats. Indian J Exp Biol, 30, 738–740.
  • Chávez E, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. (2008). Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J Appl Toxicol, 28, 35–43.
  • Chen J, Nikolovska-Coleska Z, Wang G, Qiu S, Wang S. (2006). Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorg Med Chem Lett, 16, 5805–5808.
  • Chirdchupunseree H, Pramyothin P. (2010). Protective activity of phyllanthin in ethanol-treated primary culture of rat hepatocytes. J Ethnopharmacol, 128, 172–176.
  • Dange SV, Shah KU, Bulakh PM, Joshi DR. (1992). Efficacy of stimuliv, an indigenous compound formulation, against hepatotoxicity of antitubercular drugs–a double blind study. Indian J Chest Dis Allied Sci, 34, 175–183.
  • De Smet PA. (2002). Herbal remedies. N Engl J Med, 347, 2046–2056.
  • Dehmlow C, Erhard J, de Groot H. (1996). Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology, 23, 749–754.
  • Devi KP, Sreepriya M, Balakrishna K, Devaki T. (2004). Protective effect of Premna tomentosa (L. Verbenaceae) extract on membrane-bound phosphatases and inorganic cations transport in acetaminophen-induced hepatotoxicity rats. J Ethnopharmacol, 93, 371–375.
  • Dhanabal SP, Syamala G, Satish Kumar MN, Suresh B. (2006). Hepatoprotective activity of the Indian medicinal plant Polygala arvensis on d-galactosamine-induced hepatic injury in rats. Fitoterapia, 77, 472–474.
  • Dwivedi Y, Rastogi R, Chander R, Sharma SK, Kapoor NK, Garg NK, Dhawan BN. (1990). Hepatoprotective activity of picroliv against carbon tetrachloride-induced liver damage in rats. Indian J Med Res, 92, 195–200.
  • Dwivedi Y, Rastogi R, Garg NK, Dhawan BN. (1993). Perfusion with picroliv reverses biochemical changes induced in livers of rats toxicated with galactosamine or thioacetamide. Planta Med, 59, 418–420.
  • Dwivedi Y, Rastogi R, Sharma SK, Garg NK, Dhawan BN. (1991). Picroliv affords protection against thioacetamide-induced hepatic damage in rats. Planta Med, 57, 25–28.
  • El-Agamy DS. (2010). Comparative effects of curcumin and resveratrol on aflatoxin B(1)-induced liver injury in rats. Arch Toxicol, 84, 389–396.
  • El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT. (2009). A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine, 16, 391–400.
  • Farghali H, Cerný D, Kameníková L, Martínek J, Horínek A, Kmonícková E, Zídek Z. (2009). Resveratrol attenuates lipopolysaccharide-induced hepatitis in d-galactosamine sensitized rats: Role of nitric oxide synthase 2 and heme oxygenase-1. Nitric Oxide, 21, 216–225.
  • Farombi EO, Shrotriya S, Na HK, Kim SH, Surh YJ. (2008). Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol, 46, 1279–1287.
  • Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M. (1989). [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Orv Hetil, 130, 2723–2727.
  • Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B. (1989). Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol, 9, 105–113.
  • Flora K, Hahn M, Rosen H, Benner K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol, 93, 139–143.
  • Flora KD, Rosen HR, Benner KG. (1996). The use of naturopathic remedies for chronic liver disease. Am J Gastroenterol, 91, 2654–2655.
  • Fogden E, Neuberger J. (2003). Alternative medicines and the liver. Liver Int, 23, 213–220.
  • Gao J, Chen J, Tang X, Pan L, Fang F, Xu L, Zhao X, Xu Q. (2006). Mechanism underlying mitochondrial protection of asiatic acid against hepatotoxicity in mice. J Pharm Pharmacol, 58, 227–233.
  • Gao J, Dou H, Tang XH, Xu LZ, Fan YM, Zhao XN. (2004). Inhibitory effect of TCCE on CCl4-induced overexpression of IL-6 in acute liver injury. Acta Biochim Biophys Sin (Shanghai), 36, 767–772.
  • Gao J, Tang X, Dou H, Fan Y, Zhao X, Xu Q. (2004). Hepatoprotective activity of Terminalia catappa L. leaves and its two triterpenoids. J Pharm Pharmacol, 56, 1449–1455.
  • Girish C, Koner BC, Jayanthi S, Ramachandra Rao K, Rajesh B, Pradhan SC. (2009a). Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharmacol, 23, 735–745.
  • Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. (2009b). Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice. Indian J Med Res, 129, 569–578.
  • Gopal N, Sengottuvelu S. (2008). Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats. Fitoterapia, 79, 24–26.
  • Gupta NK, Dixit VK. (2009a). Evaluation of hepatoprotective activity of Cleome viscosa Linn. extract. Indian J Pharmacol, 41, 36–40.
  • Gupta NK, Dixit VK. (2009b). Hepatoprotective activity of Cleome viscosa Linn. extract against thioacetamide-induced hepatotoxicity in rats. Nat Prod Res, 23, 1289–1297.
  • Gupta YK, Sharma M, Chaudhary G, Katiyar CK. (2004). Hepatoprotective effect of New Livfit, a polyherbal formulation, is mediated through its free radical scavenging activity. Phytother Res, 18, 362–364.
  • Ha KT, Yoon SJ, Choi DY, Kim DW, Kim JK, Kim CH. (2005). Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol, 96, 529–535.
  • Hall CA, Cuppett SL. (1997). Structure-activities of natural antioxidants, in Antioxidant Methodology In Vivo and in Vitro Concepts, Ed by Auroma OI and Cuppett SL, AOCS Press, Champaign, IL, pp. 141–172.
  • Handa SS, Sharma A. (1990a). Hepatoprotective activity of andrographolide against galactosamine & paracetamol intoxication in rats. Indian J Med Res, 92, 284–292.
  • Handa SS, Sharma A. (1990b). Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Indian J Med Res, 92, 276–283.
  • Harish, R., Shivanandappa, T. (2006). Antioxidant activity and hepatoprotective potential of Phyllanthus niruri. Food Chem, 95, 180–185.
  • Hidaka I, Hino K, Korenaga M, Gondo T, Nishina S, Ando M, Okuda M, Sakaida I. (2007). Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein. Liver Int, 27, 845–853.
  • Hsieh CC, Fang HL, Lina WC. (2008). Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice. J Ethnopharmacol, 119, 117–121.
  • Huseini HF, Alavian SM, Heshmat R, Heydari MR, Abolmaali K. (2005). The efficacy of Liv-52 on liver cirrhotic patients: A randomized, double-blind, placebo-controlled first approach. Phytomedicine, 12, 619–624.
  • Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. (2007). Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharm Res, 30, 1309–1317.
  • Jain A, Soni M, Deb L, Jain A, Rout SP, Gupta VB, Krishna KL. (2008). Antioxidant and hepatoprotective activity of ethanolic and aqueous extracts of Momordica dioica Roxb. leaves. J Ethnopharmacol, 115, 61–66.
  • Janbaza KH, Gilanib AH. (2000). Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia, 71, 25–33.
  • Jeong GS, Lee DS, Li B, Byun E, Kwon DY, Park H, Kim YC. (2010). Protective effect of sauchinone by upregulating heme oxygenase-1 via the P38 MAPK and Nrf2/ARE pathways in HepG2 cells. Planta Med, 76, 41–47.
  • Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK, Chun HK. (2002). Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: Inhibition of cytochrome P450 2E1 expression. Pharmacol Res, 46, 221–227.
  • Johnson VJ, Osuchowski MF, He Q, Sharma RP. (2002). Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: II. Alterations in thymic differentiation correlate with changes in c-myc gene expression. Planta Med, 68, 961–965.
  • Joshi R, Kamat JP, Mukherjee T. (2007). Free radical scavenging reactions and antioxidant activity of embelin: Biochemical and pulse radiolytic studies. Chem Biol Interact, 167, 125–134.
  • Kaláb M, Krechler T. (1997). [The effect of the heptoprotective agent LIV 52 on liver damage]. Cas Lek Cesk, 136, 758–760.
  • Kamdem RE, Sang S, Ho CT. (2002). Mechanism of the superoxide scavenging activity of neoandrographolide - a natural product from Andrographis paniculata Nees. J Agric Food Chem, 50, 4662–4665.
  • Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH. (2002). Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther, 302, 138–144.
  • Kapil A, Koul IB, Banerjee SK, Gupta BD. (1993). Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol, 46, 182–185.
  • Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, Gharbi N, Kamoun A, El-Fazaâ S. (2007). Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci, 80, 1033–1039.
  • Kim HY, Kim JK, Choi JH, Jung JY, Oh WY, Kim DC, Lee HS, Kim YS, Kang SS, Lee SH, Lee SM. (2010). Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice. J Pharmacol Sci, 112, 105–112.
  • Kim WR, Brown RS Jr, Terrault NA, El-Serag H. (2002). Burden of liver disease in the United States: Summary of a workshop. Hepatology, 36, 227–242.
  • Krithika R, Mohankumar R, Verma RJ, Shrivastav PS, Mohamad IL, Gunasekaran P, Narasimhan S. (2009). Isolation, characterization and antioxidative effect of phyllanthin against CCl4-induced toxicity in HepG2 cell line. Chem Biol Interact, 181, 351–358.
  • Kumada H. (2002). Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology, 62 Suppl 1, 94–100.
  • Lee CH, Park SW, Kim YS, Kang SS, Kim JA, Lee SH, Lee SM. (2007). Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull, 30, 1898–1904.
  • Lee CP, Shih PH, Hsu CL, Yen GC. (2007). Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. Food Chem Toxicol, 45, 888–895.
  • Lee KJ, Woo ER, Choi CY, Shin DW, Lee DG, You HJ, Jeong HG. (2004). Protective effect of acteoside on carbon tetrachloride-induced hepatotoxicity. Life Sci, 74, 1051–1064.
  • Lee MK, Kim SH, Yang H, Lim DY, Ryu JH, Lee ES, Jew SS, Park HG, Sung SH, Kim YC. (2009). Asiatic acid derivatives protect primary cultures of rat hepatocytes against carbon tetrachloride-induced injury via the cellular antioxidant system. Nat Prod Commun, 4, 765–768.
  • Lee SJ, Ko JH, Lim K, Lim KT. (2005). 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacol Res, 51, 399–408.
  • Levy C, Seeff LD, Lindor KD. (2004). Use of herbal supplements for chronic liver disease. Clin Gastroenterol Hepatol, 2, 947–956.
  • Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL, Chou FP. (2007). Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem, 55, 3620–3628.
  • Lin HM, Tseng HC, Wang CJ, Lin JJ, Lo CW, Chou FP. (2008). Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. Chem Biol Interact, 171, 283–293.
  • Liu J, Wang ZT, Ji LL, Ge BX. (2007). Inhibitory effects of neoandrographolide on nitric oxide and prostaglandin E2 production in LPS-stimulated murine macrophage. Mol Cell Biochem, 298, 49–57.
  • Londhe JS, Devasagayam TP, Foo LY, Ghaskadbi SS. (2008). Antioxidant activity of some polyphenol constituents of the medicinal plant Phyllanthus amarus Linn. Redox Rep, 13, 199–207.
  • Luper S. (1998). A review of plants used in the treatment of liver disease: part 1. Altern Med Rev, 3, 410–421.
  • Ma K, Zhang Y, Zhu D, Lou Y. (2009). Protective effects of asiatic acid against d-galactosamine/lipopolysaccharide-induced hepatotoxicity in hepatocytes and kupffer cells co-cultured system via redox-regulated leukotriene C4 synthase expression pathway. Eur J Pharmacol, 603, 98–107.
  • Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. (1999). Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J Immunol, 163, 6800–6809.
  • Mayer KE, Myers RP, Lee SS. (2005). Silymarin treatment of viral hepatitis: A systematic review. J Viral Hepat, 12, 559–567.
  • Michielsen PP, Francque SM, van Dongen JL. (2005). Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol, 3, 27.
  • Miller AL. (1996). Antioxidant flavonoids: Structure, function and clinical usage. Altern Med Rev, 1, 103–111.
  • Mitra SK, Seshadri SJ, Venkataranganna MV, Gopumadhavan S, Udupa UV, Sarma DN. (2000). Effect of HD-03–a herbal formulation in galactosamine-induced hepatopathy in rats. Indian J Physiol Pharmacol, 44, 82–86.
  • Mitra SK, Venkataranganna MV, Gopumadhavan S, Anturlikar SD, Seshadri SJ, Venkatesha Udupa U. (2001). The protective effect of HD-03 in CCl4-induced hepatic encephalopathy in rats. Phytother Res, 15, 493–496.
  • Mitra SK, Venkataranganna MV, Sundaram R, Gopumadhavan S. (1998). Protective effect of HD-03, a herbal formulation, against various hepatotoxic agents in rats. J Ethnopharmacol, 63, 181–186.
  • Miyake K, Tango T, Ota Y, Mitamura K, Yoshiba M, Kako M, Hayashi S, Ikeda Y, Hayashida N, Iwabuchi S, Sato Y, Tomi T, Funaki N, Hashimoto N, Umeda T, Miyazaki J, Tanaka K, Endo Y, Suzuki H. (2002). Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J Gastroenterol Hepatol, 17, 1198–1204.
  • Miyakoshi M, Yamaguchi Y, Takagaki R, Mizutani K, Kambara T, Ikeda T, Zaman MS, Kakihara H, Takenaka A, Igarashi K. (2004). Hepatoprotective effect of sesquiterpenes in turmeric. Biofactors, 21, 167–170.
  • Morikawa T, Pan Y, Ninomiya K, Imura K, Matsuda H, Yoshikawa M, Yuan D, Muraoka O. (2010). Acylated phenylethanoid oligoglycosides with hepatoprotective activity from the desert plant Cistanche tubulosa. Bioorg Med Chem, 18, 1882–1890.
  • Mukherjee T, Joshi R, Kamat JP. (2007). Free radical scavenging reactions and antioxidant activity of embelin: Biochemical and pulse radiolytic studies. Chem Biol Interact, 167, 125–134.
  • Mulla WA, Salunkhe VR, Bhise SB. (2009). Hepatoprotective activity of hydroalcoholic extract of leaves of Alocasia indica (Linn.). Indian J Exp Biol, 47, 816–821.
  • Muriel P, Garciapiña T, Perez-Alvarez V, Mourelle M. (1992). Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol, 12, 439–442.
  • Muriel P, Mourelle M. (1990). Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol, 10, 275–279.
  • Naik RS, Mujumdar AM, Ghaskadbi S. (2004). Protection of liver cells from ethanol cytotoxicity by curcumin in liver slice culture in vitro. J Ethnopharmacol, 95, 31–37.
  • Nayak S, Sashidhar RB. (2010). Metabolic intervention of aflatoxin B1 toxicity by curcumin. J Ethnopharmacol, 127, 641–644.
  • Oliveira FA, Chaves MH, Almeida FR, Lima RC Jr, Silva RM, Maia JL, Brito GA, Santos FA, Rao VS. (2005). Protective effect of alpha- and beta-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice. J Ethnopharmacol, 98, 103–108.
  • Orhan DD, Orhan N, Ergun E, Ergun F. (2007). Hepatoprotective effect of Vitis vinifera L. leaves on carbon tetrachloride-induced acute liver damage in rats. J Ethnopharmacol, 112, 145–151.
  • Parabia, MH, Adhvaryu MR, Reddy N. (2007). Effects of four Indian medicinal herbs on Isoniazid, Rifampicin and Pyrazinamide induced hepatic injury and immunosuppression in guinea pigs. World J Gastroenterol, 13, 3199–205.
  • Pradhan SC, Girish C. (2006). Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res, 124, 491–504.
  • Raja S, Ahamed KF, Kumar V, Mukherjee K, Bandyopadhyay A, Mukherjee PK. (2007). Antioxidant effect of Cytisus scoparius against carbon tetrachloride treated liver injury in rats. J Ethnopharmacol, 109, 41–47.
  • Rajesh MG, Latha MS. (2004). Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol, 91, 99–104.
  • Ram VJ. (2001). Herbal preparations as a source of hepatoprotective agents. Drug News Perspect, 14, 353–363.
  • Rao GM, Rao CV, Pushpangadan P, Shirwaikar A. (2006). Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. J Ethnopharmacol, 103, 484–490.
  • Rastogi R, Saksena S, Garg NK, Kapoor NK, Agarwal DP, Dhawan BN. (1996). Picroliv protects against alcohol-induced chronic hepatotoxicity in rats. Planta Med, 62, 283–285.
  • Rawat AK, Mehrotra S, Tripathi SC, Shome U. (1997). Hepatoprotective activity of Boerhaavia diffusa L. roots–a popular Indian ethnomedicine. J Ethnopharmacol, 56, 61–66.
  • Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. (2007). Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta, 1770, 989–996.
  • Rice-Evans CA, Miller NJ, Paganga G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med, 20, 933–956.
  • Rivera-Espinoza Y, Muriel P. (2009). Pharmacological actions of curcumin in liver diseases or damage. Liver Int, 29, 1457–1466.
  • Rubiolo JA, Mithieux G, Vega FV. (2008). Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol, 591, 66–72.
  • Rubiolo JA, Vega FV. (2008). Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species. Biomed Pharmacother, 62, 606–612.
  • Saliou C, Rihn B, Cillard J, Okamoto T, Packer L. (1998). Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways. FEBS Lett, 440, 8–12.
  • Saller R, Meier R, Brignoli R. (2001). The use of silymarin in the treatment of liver diseases. Drugs, 61, 2035–2063.
  • Saller R, Melzer J, Reichling J, Brignoli R, Meier R. (2007). An updated systematic review of the pharmacology of silymarin. Forsch Komplementmed, 14, 70–80.
  • Sanmugapriya E, Venkataraman S. (2006). Studies on hepatoprotective and antioxidant actions of Strychnos potatorum Linn. seeds on CCl4-induced acute hepatic injury in experimental rats. J Ethnopharmacol, 105, 154–160.
  • Santra A, Das S, Maity A, Rao SB, Mazumder DN. (1998). Prevention of carbon tetrachloride-induced hepatic injury in mice by Picrorhiza kurrooa. Indian J Gastroenterol, 17, 6–9.
  • Sathesh Kumar S, Ravi Kumar B, Krishna Mohan G. (2009). Hepatoprotective effect of Trichosanthes cucumerina var cucumerina L. on carbon tetrachloride induced liver damage in rats. J Ethnopharmacol, 123, 347–350.
  • Schuppan D, Jia JD, Brinkhaus B, Hahn EG. (1999). Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology, 30, 1099–1104.
  • Sebai H, Sani M, Yacoubi MT, Aouani E, Ghanem-Boughanmi N, Ben-Attia M. (2010). Resveratrol, a red wine polyphenol, attenuates lipopolysaccharide-induced oxidative stress in rat liver. Ecotoxicol Environ Saf, 73, 1078–1083.
  • Sharma M, Tripathi P, Singh VP, Tripathi YB. (1995). Hepatoprotective and toxicological evaluation of hepatomed, an ayurvedic drug. Indian J Exp Biol, 33, 34–37.
  • Shiki Y, Shirai K, Saito Y, Yoshida S, Mori Y, Wakashin M. (1992). Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody. J Gastroenterol Hepatol, 7, 12–16.
  • Singh B, Saxena AK, Chandan BK, Agarwal SG, Anand KK. (2001). In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves. Indian J Physiol Pharmacol, 45, 435–441.
  • Singh D, Singh R, Singh P, Gupta RS. (2009). Effects of embelin on lipid peroxidation and free radical scavenging activity against liver damage in rats. Basic Clin Pharmacol Toxicol 105, 243–248.
  • Singha PK, Roy S, Dey S. (2007). Protective activity of andrographolide and arabinogalactan proteins from Andrographis paniculata Nees. against ethanol-induced toxicity in mice. J Ethnopharmacol, 111, 13–21.
  • Sonnenbichler J, Zetl I. (1986). Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res, 213, 319–331.
  • Sreepriya M, Bali G. (2005). Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia, 76, 549–555.
  • Sreepriya M, Bali G. (2006). Effects of administration of embelin and curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem, 284, 49–55.
  • Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB. (2002). Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol, 97, 2391–2397.
  • Suja SR, Latha PG, Pushpangadan P, Rajasekharan S. (2004). Evaluation of hepatoprotective effects of Helminthostachys zeylanica (L.) Hook against carbon tetrachloride-induced liver damage in Wistar rats. J Ethnopharmacol, 92, 61–66.
  • Sun ZL, Wang Y, Guo ML, Li YX. (2010). Two new hepaprotective saponins from Semen celosiae. Fitoterapia, 81, 375–380.
  • Sung SH, Kim YC. (2000). Hepatoprotective diastereomeric lignans from Saururus chinensis herbs. J Nat Prod, 63, 1019–1021.
  • Sung SH, Lee EJ, Cho JH, Kim HS, Kim YC. (2000). Sauchinone, a lignan from Saururus chinensis, attenuates CCl4-induced toxicity in primary cultures of rat hepatocytes. Biol Pharm Bull, 23, 666–668.
  • Takahara T, Watanabe A, Shiraki K. (1994). Effects of glycyrrhizin on hepatitis B surface antigen: A biochemical and morphological study. J Hepatol, 21, 601–609.
  • Tang X, Gao J, Wang Y, Fan YM, Xu LZ, Zhao XN, Xu Q, Qian ZM. (2006). Effective protection of Terminalia catappa L. leaves from damage induced by carbon tetrachloride in liver mitochondria. J Nutr Biochem, 17, 177–182.
  • Tome S, Lucey MR. (2004). Review article: Current management of alcoholic liver disease. Aliment Pharmacol Ther, 19, 707–714.
  • Torres M, Rodríguez-Serrano F, Rosario DJ, Rodríguez-Perez F, Toro DH. (2004). Does Silybum marianum play a role in the treatment of chronic hepatitis C? P R Health Sci J, 23, 69–74.
  • Upadhyay G, Singh AK, Kumar A, Prakash O, Singh MP. (2008). Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur J Pharmacol, 596, 146–152.
  • Verma PC, Basu V, Gupta V, Saxena G, Rahman LU. (2009). Pharmacology and chemistry of a potent hepatoprotective compound Picroliv isolated from the roots and rhizomes of Picrorhiza kurroa Royle ex benth. (kutki). Curr Pharm Biotechnol, 10, 641–649.
  • Vidyashankar S, K Mitra S, Nandakumar KS. (2010). Liv.52 protects HepG2 cells from oxidative damage induced by tert-butyl hydroperoxide. Mol Cell Biochem, 333, 41–48.
  • Vidyashankar S, Patki PS. (2010). Liv.52 attenuate copper induced toxicity by inhibiting glutathione depletion and increased antioxidant enzyme activity in HepG2 cells. Food Chem Toxicol, 48, 1863–1868.
  • Visen PKS, Shukia B, Patnaik GK, Dhawan BN. (1993). Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol, 40, 131–136.
  • Vitaglione P, Ottanelli B, Milani S, Morisco F, Caporaso N, Fogliano V. (2009). Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation. J Gastroenterol Hepatol, 24, 618–622.
  • Wang F, Zhou HY, Zhao G, Fu LY, Cheng L, Chen JG, Yao WX. (2004). Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol, 10, 2842–2845.
  • Wang JY, Guo JS, Li H, Liu SL, Zern MA. (1998). Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats. Liver, 18, 180–185.
  • Wang L, Cheng D, Wang H, Di L, Zhou X, Xu T, Yang X, Liu Y. (2009). The hepatoprotective and antifibrotic effects of Saururus chinensis against carbon tetrachloride induced hepatic fibrosis in rats. J Ethnopharmacol, 126, 487–491.
  • Wang T, Sun NL, Zhang WD, Li HL, Lu GC, Yuan BJ, Jiang H, She JH, Zhang C. (2008). Protective effects of dehydrocavidine on carbon tetrachloride-induced acute hepatotoxicity in rats. J Ethnopharmacol, 117, 300–308.
  • Wiseman H. (1996). Dietary influences on membrane function: Importance in protection against oxidative damage and disease. J Nutr Biochem, 7, 2–5.
  • Xin-Hua W, Chang-Qing L, Xing-Bo G, Lin-Chun F. (2001). A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. Southeast Asian J Trop Med Public Health, 32, 140–142.
  • Xiong Q, Hase K, Tezuka Y, Namba T, Kadota S. (1999). Acteoside inhibits apoptosis in d-galactosamine and lipopolysaccharide-induced liver injury. Life Sci, 65, 421–430.
  • Xiong Q, Hase K, Tezuka Y, Tani T, Namba T, Kadota S. (1998). Hepatoprotective activity of phenylethanoids from Cistanche deserticola. Planta Med, 64, 120–125.
  • Xiong Q, Kadota S, Tani T, Namba T. (1996). Antioxidative effects of phenylethanoids from Cistanche deserticola. Biol Pharm Bull, 19, 1580–1585.
  • Xue Q, Sun ZL, Guo ML, Wang Y, Zhang G, Wang XK. (2010). Two new compounds from Semen celosiae and their protective effects against CCl(4)-induced hepatotoxicity. Nat Prod Res, 1–8.
  • Yang BS, Ma YJ, Wang Y, Chen LY, Bi MR, Yan BZ, Bai L, Zhou H, Wang FX. (2007). Protective effect and mechanism of stronger neo-minophagen C against fulminant hepatic failure. World J Gastroenterol, 13, 462–466.
  • Yanpallewar SU, Sen S, Tapas S, Kumar M, Raju SS, Acharya SB. (2003). Effect of Azadirachta indica on paracetamol-induced hepatic damage in albino rats. Phytomedicine, 10, 391–396.
  • Yoshikawa M, Matsui Y, Kawamoto H, Umemoto N, Oku K, Koizumi M, Yamao J, Kuriyama S, Nakano H, Hozumi N, Ishizaka S, Fukui H. (1997). Effects of glycyrrhizin on immune-mediated cytotoxicity. J Gastroenterol Hepatol, 12, 243–248.
  • Zeashan H, Amresh G, Singh S, Rao CV. (2008). Hepatoprotective activity of Amaranthus spinosus in experimental animals. Food Chem Toxicol, 46, 3417–3421.
  • Zhang L, Li HZ, Gong X, Luo FL, Wang B, Hu N, Wang CD, Zhang Z, Wan JY. (2010). Protective effects of Asiaticoside on acute liver injury induced by lipopolysaccharide/d-galactosamine in mice. Phytomedicine, 17, 811–819.
  • Zhang L, Wang B. (2002). Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B. Hepatol Res, 24, 220.
  • Zhao J, Liu T, Ma L, Yan M, Zhao Y, Gu Z, Huang Y. (2009). Protective effect of acteoside on immunological liver injury induced by Bacillus Calmette-Guerin plus lipopolysaccharide. Planta Med, 75, 1463–1469.
  • Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ, Zhang GL. (2008). Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats. Biomed Pharmacother, 62, 567–572.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.